1. Home
  2. SGHT vs CFFI Comparison

SGHT vs CFFI Comparison

Compare SGHT & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • CFFI
  • Stock Information
  • Founded
  • SGHT 2011
  • CFFI 1927
  • Country
  • SGHT United States
  • CFFI United States
  • Employees
  • SGHT N/A
  • CFFI N/A
  • Industry
  • SGHT Medical Specialities
  • CFFI Major Banks
  • Sector
  • SGHT Health Care
  • CFFI Finance
  • Exchange
  • SGHT Nasdaq
  • CFFI Nasdaq
  • Market Cap
  • SGHT 193.2M
  • CFFI 218.0M
  • IPO Year
  • SGHT 2021
  • CFFI 1998
  • Fundamental
  • Price
  • SGHT $3.45
  • CFFI $66.53
  • Analyst Decision
  • SGHT Buy
  • CFFI
  • Analyst Count
  • SGHT 8
  • CFFI 0
  • Target Price
  • SGHT $4.21
  • CFFI N/A
  • AVG Volume (30 Days)
  • SGHT 103.2K
  • CFFI 5.6K
  • Earning Date
  • SGHT 11-06-2025
  • CFFI 10-28-2025
  • Dividend Yield
  • SGHT N/A
  • CFFI 2.79%
  • EPS Growth
  • SGHT N/A
  • CFFI 32.15
  • EPS
  • SGHT N/A
  • CFFI 7.56
  • Revenue
  • SGHT $76,303,000.00
  • CFFI $122,075,000.00
  • Revenue This Year
  • SGHT N/A
  • CFFI N/A
  • Revenue Next Year
  • SGHT $12.04
  • CFFI N/A
  • P/E Ratio
  • SGHT N/A
  • CFFI $8.80
  • Revenue Growth
  • SGHT N/A
  • CFFI 7.42
  • 52 Week Low
  • SGHT $2.03
  • CFFI $53.14
  • 52 Week High
  • SGHT $6.29
  • CFFI $89.90
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 42.70
  • CFFI 41.03
  • Support Level
  • SGHT $3.20
  • CFFI $65.50
  • Resistance Level
  • SGHT $3.43
  • CFFI $69.58
  • Average True Range (ATR)
  • SGHT 0.14
  • CFFI 1.51
  • MACD
  • SGHT -0.00
  • CFFI -0.42
  • Stochastic Oscillator
  • SGHT 46.79
  • CFFI 17.25

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

Share on Social Networks: